Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update

Read more ››
By: GlobenewsWire - 31 Mar 2023
Related companies:  Molecular Templates, Inc.

SeaStar Medical Reports 2022 Financial Results and Provides a Business Update

Read more ››
By: GlobenewsWire - 31 Mar 2023
Related companies:  SeaStar Medical

HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer

Read more ››
By: GlobenewsWire - 31 Mar 2023
Related companies:  HUTCHMED

Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights

Read more ››
By: GlobenewsWire - 31 Mar 2023
Related companies:  Checkpoint Therapeutics, Inc.

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2022

Read more ››
By: PR Newswire Association LLC. - 31 Mar 2023
Related companies:  Everest Medicines (Shanghai)

Methodist Le Bonheur Healthcare welcomes Joe Pantoliano to annual Mental Health Breakfast

Read more ››
By: PR Newswire Association LLC. - 31 Mar 2023

EISAI PRESENTED NEW ANALYSES OF ARIA AND QOL ON LECANEMAB IN CLARITY AD AT THE AD/PD™ 2023 ANNUAL MEETING

Read more ››
By: PR Newswire Association LLC. - 31 Mar 2023
Related companies:  Biogen Inc.

ADDITIONAL DETAILED ANALYSES FROM PHASE 2 STUDY 201 OF LECANEMAB PUBLISHED AS THREE PAPERS IN PEER-REVIEWED JOURNALS

Read more ››
By: PR Newswire Association LLC. - 31 Mar 2023
Related companies:  Biogen Inc.

CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  OpGen, Inc.

Willow Industries and AirAnswers® Revolutionize the Science Behind Cannabis Cultivation Compliance

Read more ››
By: GlobenewsWire - 30 Mar 2023

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Eledon Pharmaceuticals, Inc.

Y-mAbs Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Y-mAbs Therapeutics Inc.

Nkarta Announces Departure of Chief Financial & Business Officer

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Nkarta Inc.

Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Surgalign Holdings, Inc.

Invivyd Doses First Participants in Phase 1 Trial of VYD222, a Novel Monoclonal Antibody Candidate for COVID-19

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Invivyd, Inc.

Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Fresh Tracks Therapeutics

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Biora Therapeutics, Inc.

Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Avenue Therapeutics, Inc.

Aprea Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Update on Business Operations

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  Aprea Therapeutics, Inc.

ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Read more ››
By: GlobenewsWire - 30 Mar 2023
Related companies:  ProSomnus Inc.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »